Sign In
Buy ESTA
$92.54
-0.94 (-1.01%)
At Close: Jul 31, 2026
Baron Discovery Fund Q4 2025: Winners, Laggards, Buys & Sells
06:08pm, Sunday, 15'th Feb 2026
In the fourth quarter of 2025, the Baron Discovery Fund returned 0.19% (Institutional Shares), trailing the Russell 2000 Growth Index by 1.03%. In these periods, low quality (high debt and poor profit
Establishment Labs to Announce Fourth Quarter 2025 Financial Results on February 24
08:00am, Tuesday, 10'th Feb 2026
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Establishment Labs (NASDAQ:ESTA) & Q Biomed (OTCMKTS:QBIO) Critical Contrast
01:15am, Tuesday, 10'th Feb 2026
Establishment Labs (NASDAQ: ESTA - Get Free Report) and Q Biomed (OTCMKTS:QBIO - Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses base
Establishment Labs: The Pivot From Growth To Profitable Scale
07:55am, Thursday, 05'th Feb 2026
Establishment Labs is transitioning to positive cash flow, ending its cash burn era and justifying its premium valuation. ESTA achieved 20% U.S. breast augmentation market share in under 18 months, ou
Establishment Labs Holdings Inc. (ESTA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
03:56pm, Wednesday, 14'th Jan 2026
Establishment Labs Holdings Inc. (ESTA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Establishment Labs Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025
08:00am, Monday, 12'th Jan 2026
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Contrasting Establishment Labs (NASDAQ:ESTA) and Tauriga Sciences (OTCMKTS:TAUG)
01:29am, Wednesday, 07'th Jan 2026
Establishment Labs (NASDAQ: ESTA - Get Free Report) and Tauriga Sciences (OTCMKTS:TAUG - Get Free Report) are both medical companies, but which is the superior business? We will compare the two compan
Establishment Labs to Present at 44th Annual J.P. Morgan Healthcare Conference
08:00am, Wednesday, 31'st Dec 2025
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
ESTA Shares Dip Despite FDA Filing for Motiva Breast Reconstruction
01:45pm, Tuesday, 30'th Dec 2025
Establishment Labs files Motiva breast implants with the FDA for reconstruction, targeting expansion beyond elective augmentation into a clinically necessary market.
Establishment Labs Submits to FDA for Approval of Motiva Implants in Breast Reconstruction
08:00am, Monday, 29'th Dec 2025
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Analyzing Omada Health (NASDAQ:OMDA) & Establishment Labs (NASDAQ:ESTA)
01:12am, Monday, 29'th Dec 2025
Establishment Labs (NASDAQ: ESTA - Get Free Report) and Omada Health (NASDAQ: OMDA - Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based
Financial Contrast: Establishment Labs (NASDAQ:ESTA) & XWELL (NASDAQ:XWEL)
02:30am, Sunday, 21'st Dec 2025
XWELL (NASDAQ: XWEL - Get Free Report) and Establishment Labs (NASDAQ: ESTA - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based
Establishment Labs Holdings Inc. (NASDAQ:ESTA) Receives Average Recommendation of “Moderate Buy” from Analysts
01:21am, Tuesday, 25'th Nov 2025
Shares of Establishment Labs Holdings Inc. (NASDAQ: ESTA - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the eight research firms that are covering the firm, MarketB
Establishment Labs to Present at Jefferies London Healthcare Conference
08:00am, Friday, 07'th Nov 2025
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Establishment Labs Holdings Inc. (ESTA) Q3 2025 Earnings Call Transcript
12:01pm, Wednesday, 05'th Nov 2025
Establishment Labs Holdings Inc. ( ESTA ) Q3 2025 Earnings Call November 5, 2025 8:30 AM EST Company Participants Rajbir Denhoy - Chief Financial Officer Filippo Caldini - CEO & Director Conference Ca
